We investigated the association between MR signal abnormalities of the central nervous system, neuropsychologic performance and exposure indices in 20 experienced elderly compressed-air divers who had no history of neurological decompression illness (DCI). Results of MRI of the brain and psychometric testing were compared with 20 matched healthy commercial employees who never dived: 60% of the divers and 45% of the controls had hyperintense MR abnormalities. Among divers, both the number and the size of abnormalities correlated with hours diving in the deep air-diving range of 40–60 m (p < 0.05). Divers’ mental flexibility and visual tracking performance were decreased in comparison with controls (p < 0.05 and p < 0.01). Divers thus are at risk of detrimental long-term effects of compressed-air diving on the central nervous system even in the absence of a history of neurological DCI.

Keywords:
Diving, Magnetic resonance imaging, Brain lesions, Psychometric testing, Cognition, Memory
1.
Dick APK, Massey EW: Neurological presentation of decompression sickness and air embolism in sport divers. Neurology 1985;35:667–671.
2.
Melamed Y, Shupak A, Bitterman H: Medical problems associated with underwater diving. N Engl J Med 1992;326:30–35.
3.
Wilmshurst PT, Byrne JC, Webb-Peploe MM: Relation between interatrial shunts and decompression sickness in divers. Lancet 1989;ii:1302–1306.
4.
Todnem K, Nyland H, Skeidsvoll H, Svihus R, Rinck P, Kambestad BK, Riise T, Aarli JA: Neurological long term consequences of deep diving. Br J Ind Med 1991;48:258–266.
5.
Todnem K, Skeidsvoll H, Svihus R, Rinck R, Riise T, Kambestad BK, Aarli JA: Electroencephalography, evoked potentials and MRI brain scans in saturation divers. An epidemiological study. Electroencephalogr Clin Neurophysiol 1991;79:322–329.
6.
Fueredi GA, Czarnecki DJ, Kindwall EP: MR findings in the brains of compressed-air tunnel workers: Relationship to psychometric results. AJNR 1991;12:67–70.
7.
Reul J, Weis J, Jung A, Willmes K, Thron A: Central nervous system lesions and cervical disc herniations in amateur divers. Lancet 1995;345:1403–1405.
8.
Edmonds C: The mythology of divers’ dementia; in Hope A, Lund T, Elliott DH, Halsey MJ, Wiig H (eds): Long Term Health Effects of Diving. Flagstaff, Best Publishing 1994, pp 229–242.
9.
Wilmshurst P: Brain damage in divers. BMJ 1997;314:659–660.
10.
Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJP, Vermersch P, Steinling M, Valk J: A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:404–408.
11.
Scheltens P, Erkinjunti T, Leys D, Wahlund LO, Inzitari D, del Ser T, Pasquier F, Barkhof F, Mäntylä R, Bowler J, Wallin A, Ghika J, Fazakas F, Pantoni L: White matter changes on CT and MRI: An overview of visual rating scales. Eur Neurol 1998;39:80–89.
12.
Spreen O, Strauss E: A Compendium of Neuropsychological Tests, ed 2. New York, Oxford University Press, 1998.
13.
Lehrl S: Manual zum MWT-B. Peri-Med, Erlangen, 1977.
14.
Nelson HE, O’Conell A: Dementia: The estimation of pre-morbid intelligence levels using a new adult reading test. Cortex 1978;14:234–244.
15.
Palmer AC, Calder IM, Yates PO: Cerebral vasculopathy in divers. Neuropathol Appl Neurobiol 1992;18:113–124.
16.
Brubakk AO: Silent vascular bubbles – Facts or fiction? in Hope A, Lund T, Elliott DH, Halsey MJ, Wiig H (eds): Long Term Health Effects of Diving. Flagstaff, Best Publishing, 1994, pp 133–145.
17.
Hills BA, James PB: Microbubble damage to the blood-brain barrier: Relevance to decompression sickness. Undersea Biomed Res 1991;18:111–116.
18.
Calder IM: Does diving damage your brain? Occup Med 1992;42:213–214.
19.
Hovens MMC, ter Riet G, Visser GH: Long-term adverse effects of scuba diving. Lancet 1995;346:384–385.
20.
Knauth M, Ries S, Pohlmann S, Kerby T, Forsting M, Daffertshofer M, Hennerici M, Sartor K: Cohort study of multiple brain lesions in sport divers: Role of a patent foramen ovale. BMJ 1997;314:701–705.
21.
Wilmshurst P, Edge CJ, Bryson P: Long-term adverse effects of scuba diving. Lancet 1995;346:384.
22.
Rydberg JN, Hammond CA, Grimm RC, Erickson BJ, Jack CR Jr, Huston J 3rd, Riederer SJ: Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 1994;193:173–180.
23.
Gerard G, Weisberg LA: MRI periventricular lesions in adults. Neurology 1986;36:998–1001.
24.
Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Paver F, Freidl W, Niederkorn K, Lechner H: Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. Arch Neurol 1992;49:825–827.
25.
Rinck PA, Svihus R, De Francisco P: MR imaging of the central nervous system in divers. J Magn Reson Imaging 1991;1:293–299.
26.
Fazekas F: Magnetic resonance signal abnormalities in asymptomatic individuals: Their incidence and functional correlates. Eur Neurol 1989;29:164–168.
27.
Lezak MD: Neuropsychological assessment, ed 3. New York, Oxford University Press, 1995.
28.
Vaernes RJ, Klove H, Ellertsen B: Neuropsychological effects of saturation diving. Undersea Biomed Res 1989;16:223–251.
© 1999 S. Karger AG, Basel
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.